About

Tyler Benedum has served as Aktis Oncology's Chief Technical Officer since May 2024, having joined the company in January 2022 as Senior Vice President, CMC. From 2005 to 2022 he held positions of increasing seniority at Avid Radiopharmaceuticals (acquired by Eli Lilly and Company), most recently as Vice President of CMC Development and Manufacturing. He received a BS in Chemistry from Washington College and a PhD in Organic Chemistry from the University of Virginia.

Roles

Aktis Oncology, Inc.
Chief Technical Officer · Current role
May 2024–present
Aktis Oncology, Inc.
Senior Vice President, CMC
January 2022 - May 2024
Avid Radiopharmaceuticals Inc.
Vice President of CMC Development and Manufacturing · Avid was acquired by Eli Lilly and Company
August 2005 - January 2022

Also at Aktis Oncology, Inc.

Related

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.